Work

Rationale for a randomized, placebo-controlled, Phase 2 study of Rejuveinix (RJX) in COVID-19 patients with acute lung injury and hypoxemic respiratory failure

Year: 2020

Type: article

Study design: Study Protocol

Source: Clinical Investigation

DOI: 10.37532/2041-6792.2020.10(3).168

Authors: Kristina Cabala, Jackie Earabino, Peter Pacult, Fatih M. Uckun

Language: English

Topic: COVID-19 Clinical Research Studies

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3049038657

FWCI: 0.164

Cites:

Cited by: 5

Related to: 10